14.28
18.86%
-3.32
Pre-mercato:
14.90
0.62
+4.34%
Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
38.91%
1.7556
|
1.2638 | 1.1426 | 1.0262 | 4.2002 |
Operating Income/Loss |
38.91%
-1.7556
|
-1.2638 | -1.1426 | -1.0262 | -4.2002 |
Nonoperating Income/Loss |
22.91%
0.0923
|
0.1198 | 0.1061 | 0.0232 | -0.9733 |
Income/Loss From Continuing Operations Before Tax |
45.38%
-1.6633
|
-1.1441 | -1.0365 | -1.003 | -5.1736 |
Income/Loss From Continuing Operations After Tax |
45.38%
-1.6633
|
-1.1441 | -1.0365 | -1.003 | -5.1736 |
Net Income/Loss
|
45.38%
-1.6633
|
-1.1441 | -1.0365 | -1.003 | -5.1736 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | -1.003 | -5.1736 |
Basic Average Shares |
1,781%
16.01
|
0.8512 | 15.40 | 11.72 | 10.77 |
Diluted Average Shares |
1,781%
16.01
|
0.8512 | 15.40 | 11.72 | 10.77 |
Basic Earnings Per Share |
100.00%
-0.10
|
-0.05 | -0.07 | -0.09 | -0.48 |
Diluted Earnings Per Share |
100.00%
-0.10
|
-0.05 | -0.07 | -0.09 | -0.48 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):